You searched for "outcome"
Verteporfin shortage: treatment options and outcomes in chronic non-resolving central serous chorioretinopathy
Half-dose photodynamic therapy (HD-PDT) with verteporfin has been the therapy of choice in non-resolving central serous chorioretinopathy lasting longer than four months. Since 2021, a worldwide shortage of verteporfin due to manufacturing issues prompted adjustments in treatment practices. This retrospective,...
Outcomes in intermediate age-related macular degeneration (AMD): A MACUSTAR study report
Intermediate AMD (iAMD) is the most high-risk AMD stage for progressing to late AMD. This article gives the report of the MACUSTAR study. A wide range of assessments were conducted across 20 sites in seven European countries, in accordance with...College comments on the DHSC’s update on GOS sight test fees for England and clinical placement training payments for 2025/2026
This week, the Department of Health and Social Care published details of its confirmed NHS sight test fee and NHS domiciliary fees from 1 April 2025, continuing professional development payments for 2024, and clinical placement training payments from 1 April...Learnings and trends in the management of open-angle and angle-closure glaucoma
To be truly disruptive, newer technologies need to offer a quality of life benefit over medication to a broad population of glaucoma sufferers. Evidence and converging trends in medical and surgical management of glaucoma were explored in counterpoint discussions and...OpenEyes – Community edition
Moving to an electronic patient record (EPR) is all the rage these days, even in the District General Hospitals (DGHs). When I am not writing these articles I work in one such hospital. At Bolton Foundation Trust we deployed OpenEyes...The College of Optometrists calls for shift in detecting and managing glaucoma
The College of Optometrists calls for shift in detecting and managing glaucoma by fully unlocking safe and effective primary care capacity Glaucoma is the second leading cause of irreversible sight loss in the UK and affects over one million people,...What’s new in glaucoma? Clinical trials drive practice changes, surgical advancements gather pace
Rod McNeil reviews the latest developments in the treatment of glaucoma in the UK. Primary open-angle glaucoma (POAG), which accounts for over two-thirds of all glaucoma cases, has an estimated UK prevalence in 2017 of approximately 2% of people over...
